A novel dynamic risk score to predict venous thromboembolism (VTE) recurrences after 3 months of anticoagulation in patients with incident VTE and without active cancer

被引：0
|
作者：
Cohen, A. [1 ]
Choudhuri, S. [2 ]
Khan, I [3 ]
Pollock, K. [4 ]
Bober-Irizar, M. [5 ]
Galias, Z. [6 ]
Irizar, A. [5 ]
Bober, M. [7 ]
机构：
[1] Guys & St Thomas NHS Trust Hosp, London, England
[2] Northern Care Alliance NHS Fdn Trust, Manchester, England
[3] Pfizer Ltd, Tadworth, England
[4] Bristol Myers Squibb, London, England
[5] ForecomAI, London, England
[6] AGH Univ Sci & Technol, Krakow, Poland
[7] Univ Surrey, Fac Hlth & Med Sci, Guildford, England
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] The Incidence, Risk Factors, and Prognosis of Recurrent Venous Thromboembolism (VTE) in Patients with Advanced Solid Cancers Receiving Anticoagulation Therapy After the Diagnosis of Index Vte; A Korean Venous Thromboembolism Registry Study
    Yhim, Ho-Young
    Jang, Moon Ju
    Choi, Won-Il
    Lee, Yong Cheol
    Lee, Jeong-Ok
    Lee, Keun-Wook
    Bang, Soo-Mee
    Kim, Sung Hyun
    Kim, Yeo-Kyeoung
    Chang, Hye Jung
    Kwak, Jae-Yong
    Yim, Chang-Yeol
    BLOOD, 2012, 120 (21)
  • [22] Prediction of Venous Thromboembolism (VTE) in Patients with Pancreatic Cancer Using Clinical Data, Biomarkers, and VTE Risk Models
    Ruch, Joshua M.
    Bellile, Emily
    Hawley, Angela E.
    Anderson, Michelle A.
    Wakefield, Thomas W.
    Sood, Suman L.
    BLOOD, 2012, 120 (21)
  • [23] Predicting venous thromboembolism (VTE) risk in cancer patients using machine learning
    Townsley, Samir Khan
    Basu, Debraj
    Vora, Jayneel
    Wun, Ted
    Chuah, Chen-Nee
    Shankar, Prabhu R. V.
    HEALTH CARE SCIENCE, 2023, 2 (04): : 205 - 222
  • [24] Gas6 plasma levels in elderly patients with acute venous thromboembolism (VTE) predict major bleeding under anticoagulation and mortality but not recurrent VTE
    Angelillo-Scherrer, A.
    Calzavarini, S.
    Mean, M.
    LImacher, A.
    Rodondi, N.
    Aujesky, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 713 - 713
  • [25] Baseline D-dimer levels are predictive of recurrent venous thromboembolism (VTE) at 6 months in cancer patients with VTE treated with tinzaparin
    Piatek, C. I.
    Tagawa, S. T.
    Wei-Tsai, D.
    Hanna, D.
    Weitz, I. C.
    O'Connell, C.
    Rochanda, L.
    Groshen, S.
    Liebman, H. A.
    THROMBOSIS RESEARCH, 2016, 140 : S174 - S174
  • [26] Risk assessment for recurrent venous thromboembolism (VTE) after 6-14 months of anticoagulant treatment
    Raskob, G. E.
    Anthonie, L. W. A.
    Prins, M. H.
    Schellong, S.
    Buller, H. R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 857 - 858
  • [27] Are we assessing venous thromboembolism (VTE) risk appropriately for hospitalised medical patients? The National VTE Risk Assessment Tool versus Padua Prediction Score
    Chandra, Deepak
    Dabhi, Keval
    Lester, Will
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (01) : E16 - E18
  • [28] Defining the Risk: Benefit Ratio of Venous Thromboembolism (VTE) Prophylaxis in Hospitalized Cancer Patients
    Angelini, Dana E.
    Greene, Todd
    Wietzke, Julie N.
    Flanders, Scott A.
    Sood, Suman L.
    BLOOD, 2015, 126 (23)
  • [29] Differences in transitions of care among cancer patients with and without venous thromboembolism (VTE) events.
    Nathan, Cinduja
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [30] Venous Thromboembolism (VTE) Prevention with Semuloparin in Cancer Patients Initiating Chemotherapy: Benefit-Risk Assessment by VTE Risk in SAVE-ONCO
    George, Daniel
    Agnelli, Giancarlo
    Fisher, William
    Kakkar, Ajay
    Lassen, Michael R.
    Mismetti, Patrick
    Mouret, Patrick
    Lawson, Francesca
    Turpie, Alexander G. G.
    BLOOD, 2011, 118 (21) : 96 - 96
12345